Amalgamated Bank Oncocyte Corp Transaction History

Amalgamated Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $7,858 - $13,981	-9,138 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$1.15 - $2.25 $2,732 - $5,346	-2,376 Reduced 20.64%	9,138 $14,000
Q3 2021 Oct 29, 2021	SELL	$3.53 - $5.89 $3,491 - $5,825	-989 Reduced 7.91%	11,514 $41,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $6.0 $47,136 - $75,018	12,503 New	12,503 $72,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $294M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.